Original Research

Feasibility of automated artificial intelligence screening for diabetic retinopathy in a resource-limited setting

Margaretha M. Roux, James C. Rice, Jonel Steffen
Journal of the Colleges of Medicine of South Africa | Vol 3, No 1 | a269 | DOI: https://doi.org/10.4102/jcmsa.v3i1.269 | © 2025 Margaretha M. Roux, James C. Rice, Jonel Steffen | This work is licensed under CC Attribution 4.0
Submitted: 30 July 2025 | Published: 28 November 2025

About the author(s)

Margaretha M. Roux, Division of Ophthalmology, Faculty of Health Sciences, Groote Schuur Hospital and University of Cape Town, Cape Town, South Africa
James C. Rice, Division of Ophthalmology, Faculty of Health Sciences, Groote Schuur Hospital and University of Cape Town, Cape Town, South Africa
Jonel Steffen, Division of Ophthalmology, Faculty of Health Sciences, Groote Schuur Hospital and University of Cape Town, Cape Town, South Africa

Abstract

Background: Diabetic retinopathy (DR), a leading cause of blindness, requires effective screening, which is challenging in resource-limited settings. While artificial intelligence (AI) screening offers potential, real-world feasibility data are scarce.
Methods: In this prospective feasibility study, diabetic adults at a Cape Town public hospital endocrine clinic underwent DR screening with an autonomous AI system (LumineticsCore®) between April and July 2022. Ungradable images or AI-detected referable DR (moderate non-proliferative DR or worse) prompted ophthalmologist referral. Screening time, ungradable rates and referral burden were assessed.
Results: Sixty-two patients were screened, with a mean AI screening time of 11.7 min. Initial non-mydriatic images were ungradable in 39/62 (62.9%), and 19/62 (30.6%) remained ungradable despite dilatation. Overall, 55/62 (88.7%) were referred to ophthalmology, including 36 (58.1%) for AI-referable DR and 19 (30.6%) for ungradable images. Ophthalmologist assessment found that 8/62 (12.9%) required DR treatment, corresponding to a number needed to screen (NNS) of 7.8 (95% CI, 4.2 -17.9). Cataract was the main cause of AI-ungradable images.
Conclusion: AI screening time was acceptable and identified vision-threatening DR requiring treatment at a meaningful rate (about one in eight screened). However, a high initial referral burden and many ungradable images (mainly because of cataract) could overwhelm ophthalmology services without pathway adaptation.
Contribution: This study provides feasibility data on autonomous AI screening for DR in a South African public-sector clinic. Findings highlight the need for context-specific adaptations, such as raising the referral threshold to vision-threatening DR (severe non-proliferative DR, proliferative DR and/or diabetic macular oedema) and integrating protocols for managing cataract-related ungradable images, to support sustainable implementation.


Keywords

diabetic retinopathy; non-proliferative diabetic retinopathy; proliferative diabetic retinopathy; vision-threatening diabetic retinopathy; referable diabetic retinopathy; diabetic retinopathy screening; artificial intelligence; AI screening

Sustainable Development Goal

Goal 3: Good health and well-being

Metrics

Total abstract views: 125
Total article views: 221


Crossref Citations

No related citations found.